CDEK
← All drugs Report issue

ashwagandha extract

Botanicalexperimental

Clinical trial activity

32 trials · 30 clinical orgs · 0 marketing orgs

Phase 1
5
Phase 2
8
Phase 3
3
Phase 4
2

Earliest trial started May 1, 2007 (NCT00817752)

Timeline

2000s

  1. Jan 1, 2007

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2008

    Earliest Phase 3 Sponsor(trial)

2010s

  1. Jan 1, 2011

    Earliest Phase 2 Sponsor(trial)

Indications

Approved for

Studied for

Mechanism of action

  • Unspecified targetUnclear

    unclear

Chemistry & pharmacology

Loading structure…

SMILES

CC1=C(CO)C(=O)O[C@H]([C@@H](C)[C@H]2CC[C@H]3[C@@H]4C[C@H]5O[C@]56[C@@H](O)C=CC(=O)[C@]6(C)[C@H]4CC[C@]23C)C1
Mol. weight
470.61 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • ashwagandha
  • ashwagandha
  • ashwagandha extract
  • sensoril

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07210229N/AOct 1, 2025—
NCT07151261N/ASep 12, 2025National College of Natural Medicine
NCT07215689N/AJul 11, 2025SF Research Institute, Inc.
NCT07215455N/AJun 17, 2025SF Research Institute, Inc.
NCT07041853N/AJun 12, 2025University Ramon Llull
NCT07182253N/AMar 31, 2025SF Research Institute, Inc.
NCT06900569N/AMar 22, 2025University of Saskatchewan
NCT06889584N/AFeb 15, 2025University of South Carolina
NCT06972706N/AOct 26, 2024Ixoreal Biomed Inc., SF Research Institute, Inc.
NCT06716554N/AOct 26, 2024Ixoreal Biomed Inc., SF Research Institute, Inc.
NCT06714942N/AOct 25, 2024SF Research Institute, Inc.
NCT06793891N/AOct 21, 2024—
NCT06171724Early Phase 1 (Phase 1)Mar 1, 2024National Center for Advancing Translational Science (NCATS), Oregon Health and Science University
NCT06264986N/AJan 13, 2024University Ramon Llull
NCT05840731Phase 4Aug 7, 2023SF Research Institute, Inc.
NCT05831241Phase 4Jun 12, 2023SF Research Institute, Inc.
NCT05994794N/ADec 9, 2022Nutrasource Diagnostics, Standard Process Inc.
NCT05610735Phase 1/Phase 2 (Phase 2)Nov 30, 2022University of Louisville
NCT05602389N/ANov 20, 2022Vedic Lifesciences Pvt. Ltd.
NCT05684991N/ASep 19, 2022Ixoreal Biomed Inc., SF Research Institute, Inc.
Showing 20 of 32 trials
Page 1 / 2

Organizations

Research & Development (30)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
SF Research Institute, Inc.For profit9922022
Ixoreal Biomed Inc.For profit3012022
National College of Natural MedicineAcademic/Hospital2222007
University of PittsburghAcademic/Hospital2222008
University Ramon LlullAcademic/Hospital2212024
Vedic Lifesciences Pvt. Ltd.For profit2212014
Arjuna Natural Extracts Ltd.For profit1112018
Brain & Behavior Research FoundationAcademic/Hospital1012008
Helfgott Research InstituteAcademic/Hospital1012007
Katholieke Universiteit LeuvenAcademic/Hospital1012018
Loma Linda UniversityAcademic/Hospital1112017
National Center for Advancing Translational Science (NCATS)Government1012024
Natreon, Inc.For profit1112011
Nutrasource DiagnosticsFor profit1012022
Oregon Health and Science UniversityAcademic/Hospital1112024
Pharmanza Herbals Pvt LimitedFor profit1012008
Standard Process Inc.For profit1112022
Stanley Medical Research InstituteAcademic/Hospital1012018
Stem Vida InternationalFor profit1012014
Sutter HealthAcademic/Hospital1112020
30 organizations
Page 1 / 2